BCM
MDT icon

Bayesian Capital Management’s Medtronic MDT Stock Holding History

Bayesian Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,200
Closed -$628K – 701
2025
Q2 		$628K Buy
+7,200
New +$611K 0.1% 247
2024
Q4 		– Sell
-93,200
Closed -$8.39M – 866
2024
Q3 		$8.39M Buy
93,200
+51,300
+122% +$4.32M 0.98% 8
2024
Q2 		$3.3M Buy
+41,900
New +$3.43M 0.38% 58
2024
Q1 		– Sell
-33,278
Closed -$2.74M – 978
2023
Q4 		$2.74M Sell
33,278
-69,100
-67% -$5.27M 0.29% 89
2023
Q3 		$8.02M Buy
102,378
+29,500
+40% +$2.47M 0.92% 15
2023
Q2 		$6.42M Buy
+72,878
New +$6.27M 0.69% 22
2023
Q1 		– Sell
-39,978
Closed -$3.11M – 973
2022
Q4 		$3.11M Sell
39,978
-66,600
-62% -$5.4M 0.45% 25
2022
Q3 		$8.61M Buy
106,578
+80,600
+310% +$7.24M 1.74% 2
2022
Q2 		$2.33M Buy
25,978
+9,700
+60% +$983K 0.43% 28
2022
Q1 		$1.81M Buy
+16,278
New +$1.72M 0.27% 89
2021
Q3 		– Sell
-19,200
Closed -$2.38M – 476
2021
Q2 		$2.38M Sell
19,200
-8,900
-32% -$1.12M 0.62% 30
2021
Q1 		$3.32M Buy
28,100
+26,300
+1,461% +$3.08M 0.76% 25
2020
Q4 		$211K Buy
+1,800
New +$198K 0.06% 373
2019
Q4 		– Sell
-48,900
Closed -$5.31M – 690
2019
Q3 		$5.31M Buy
48,900
+8,800
+22% +$918K 1% 13
2019
Q2 		$3.9M Buy
40,100
+3,100
+8% +$283K 0.81% 19
2019
Q1 		$3.37M Sell
37,000
-32,145
-46% -$2.88M 0.65% 27
2018
Q4 		$6.29M Sell
69,145
-4,300
-6% -$402K 1.29% 4
2018
Q3 		$7.22M Buy
+73,445
New +$6.79M 1.18% 4
2018
Q1 		– Sell
-62,200
Closed -$5.02M – 732
2017
Q4 		$5.02M Buy
+62,200
New +$4.98M 1.02% 5
2017
Q2 		– Sell
-14,200
Closed -$1.14M – 532
2017
Q1 		$1.14M Buy
+14,200
New +$1.11M 0.54% 30
2016
Q1 		– Sell
-3,440
Closed -$265K – 403
2015
Q4 		$265K Buy
+3,440
New +$259K 0.38% 121

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bayesian Capital Management's MDT Position: Q3 2025 in Review

Bayesian Capital Management sold out of Medtronic (MDT) in Q3 2025, closing a stake of 7,200 shares — an estimated $628K sold.

Bayesian Capital Management first reported a position in MDT in Q4 2015 and held it in 21 quarters. The position peaked at $8.61M in Q3 2022. 2,177 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

  • Bayesian Capital Management reported no remaining Medtronic position as of Q3 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 7,200 Medtronic shares in Q3 2025, an estimated $628K.
  • Bayesian Capital Management first reported a position in Medtronic in Q4 2015 and held it in 21 quarters.
  • Bayesian Capital Management's Medtronic position peaked at $8.61M in Q3 2022.
  • 2,177 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on Bayesian Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.